What You Need to Know About the COVID-19 Vaccine
Many pharmaceutical companies urgently began developing a COVID-19 vaccine earlier this year to reduce the spread of the virus as the threat of a pandemic loomed. Fast forward several months and ...
Many pharmaceutical companies urgently began developing a COVID-19 vaccine earlier this year to reduce the spread of the virus as the threat of a pandemic loomed. Fast forward several months and ...
As COVID-19 emerged and spread in the U.S., people working and residing in long-term care facilities have experienced a significant burden of COVID-19 cases and deaths. As of Oct. 8, deaths ...
2020 has been a year of unprecedented events, and the past few months have already shown that they do not exist in a vacuum. While the country continues to respond and cope with the COVID-19 ...
The COVID-19 pandemic has underscored the consequences of decades of underfunding. To ensure we are better prepared for future pandemics and biological threats, we must consider the long-term ...
As new diseases or emergencies arise, working alongside trusted committees can help health officials quickly respond and prevent undue burden on at-risk groups such as people with disabilities, ...
Public health data collection and surveillance systems by health departments are in dire need of modernization. Though the public health community began developing a path to modernization over the ...
While COVID-19 has shown some of the best attributes of the U.S. public health system, it has exposed the weaknesses of our data systems—wrought by chronic underfunding and further exacerbated by ...
On this episode, we speak with two public health veterans who led state health departments during times of public health uncertainty—like H1N1 and Ebola. Our guests discuss the lessons they learned ...
This episode will focus on lessons learned from Oregon Health Authority’s cyanotoxin education and outreach efforts, and how a water contamination emergency caused by cyanotoxins can quickly become a ...